Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma
We could achieve successful mobilization and stem cell collection with BR120 salvage therapy in two cases.
Authors
- Noriko Yoshida
- Toru Kiguchi
- Kazunori Murai
- Yashushi Hiramatsu
- Koji Fukushima
- Tubasa Mitsutake
- Takuma Furukawa
- Ayako Takamori
- Yasuhito Terui
- Nobuhiko Uoshima
- Shinya Kimura
- Toshimi Hoshiko
- Yotaro Tamai
Institutions
- Saga University (JP)
- Iwate Prefectural Central Hospital (JP)
- SBI Pharmaceuticals (Japan) (JP)
- Saitama Medical University Hospital (JP)
- Hiroshima University Hospital (JP)
- Himeji Red Cross Hospital (JP)
- Shonan Kamakura General Hospital (JP)
- Japanese Red Cross Society Kyoto Daini Hospital (JP)
- Dokkyo Medical University (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Cureus
- Published
- 2026-02-01
- DOI
- https://doi.org/10.7759/cureus.102788
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00